Infection resistance of degradable versus non-degradable biomaterials: An assessment of the potential mechanisms

Biomaterials

Volumn 34, Issue 33, 2013, Pages 8013-8017

  Daghighi, Seyedmojtaba ^a   Sjollema, Jelmer ^a   van der Mei, Henny C ^a   Busscher, Henk J ^a   Rochford, Edward T J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Degradation; Foreign body response; Immune response; Infection

Indexed keywords

BACTERIAL INFECTIONS; FOREIGN BODY RESPONSE; IMMUNE RESPONSE; INFECTION; INFECTION RESISTANCE; POTENTIAL MECHANISM; POTENTIAL OUTCOMES; SYNTHETIC BIOMATERIALS;

BIOLOGICAL MATERIALS; DEGRADATION;

BIOMATERIALS;

BIOMATERIAL; POLYPEPTIDE ANTIBIOTIC AGENT;

ARTICLE; BACTERIAL INFECTION; BACTERIUM ADHERENCE; BIODEGRADABLE IMPLANT; BIOFILM; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMPLANT; INFECTION RESISTANCE; INFECTION RISK; NON BIODEGRADABLE IMPLANT; NONHUMAN; PRIORITY JOURNAL; VASCULARIZATION;

BACTERIA (MICROORGANISMS);

DEGRADATION; FOREIGN BODY RESPONSE; IMMUNE RESPONSE; INFECTION;

ABSORBABLE IMPLANTS; BIOCOMPATIBLE MATERIALS; FOREIGN-BODY REACTION; HUMANS;

EID: 84881660183     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.07.044     Document Type: Article

References (72)

1. Busscher H.J., Van der Mei H.C., Subbiahdoss G., Jutte P.C., Van den Dungen J.J., Zaat S.A., et al. Biomaterial-associated infection: locating the finish line in the race for the surface. Sci Transl Med 2012, 4:153rv10.
2. Bryers J.D. Medical biofilms. Biotechnol Bioeng 2008, 100:1-18.
3. Hall-Stoodley L., Costerton J.W., Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2004, 2:95-108.
4. Levy S.B., Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 2004, 10:S122-S129.
5. An Y.H., Friedman R.J. Concise review of mechanisms of bacterial adhesion to biomaterial surfaces. JBiomed Mater Res 1998, 43:338-348.
6. Harris L.G., Richards R.G. Staphylococci and implant surfaces: a review. Injury 2006, 37(Suppl.2):S3-S14.
7. Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318-1322.
8. Brady R.A., Leid J.G., Calhoun J.H., Costerton J.W., Shirtliff M.E. Osteomyelitis and the role of biofilms in chronic infection. FEMS Immunol Med Microbiol 2008, 52:13-22.
9. Fux C.A., Costerton J.W., Stewart P.S., Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol 2005, 13:34-40.
10. Stewart P.S., Costerton J.W. Antibiotic resistance of bacteria in biofilms. Lancet 2001, 358:135-138.
11. Elek S.D., Conen P.E. The virulence of Staphylococcus pyogenes for man; a study of the problems of wound infection. Br J Exp Pathol 1957, 38:573-586.
12. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20:86-100.
13. Daghighi S., Sjollema J., Jaspers V., de Boer L., Zaat S.A., Dijkstra R.J., et al. Persistence of a bioluminescent Staphylococcus aureus strain on and around degradable and non-degradable surgical meshes in a murine model. Acta Biomater 2012, 8:3991-3996.
14. Marosok R., Washburn R., Indorf A., Solomon D., Sherertz R. Contribution of vascular catheter material to the pathogenesis of infection: depletion of complement by silicone elastomer invitro. JBiomed Mater Res 1996, 30:245-250.
15. Sherertz R.J., Carruth W.A., Marosok R.D., Espeland M.A., Johnson R.A., Solomon D.D. Contribution of vascular catheter material to the pathogenesis of infection: the enhanced risk of silicone invivo. JBiomed Mater Res 1995, 29:635-645.
16. Costerton J.W. Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res 2005, 437:7-11.
17. Darouiche R.O. Treatment of infections associated with surgical implants. NEngl J Med 2004, 350:1422-1429.
18. Falagas M.E., Kapaskelis A.M., Kouranos V.D., Kakisi O.K., Athanassa Z., Karageorgopoulos D.E. Outcome of antimicrobial therapy in documented biofilm-associated infections: a review of the available clinical evidence. Drugs 2009, 69:1351-1361.
19. Gonda E., Edmundson A., Mann T. Late coronary stent infection: a unique complication after drug-eluting stent implantation. JInvasive Cardiol 2007, 19:E307-E308.
20. Casey A.L., Mermel L.A., Nightingale P., Elliott T.S. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Lancet Infect Dis 2008, 8:763-776.
21. Neut D., Dijkstra R.J., Thompson J.I., Van der Mei H.C., Busscher H.J. Antibacterial efficacy of a new gentamicin-coating for cementless prostheses compared to gentamicin-loaded bone cement. JOrthop Res 2011, 29:1654-1661.
22. Muszanska A.K., Busscher H.J., Herrmann A., Van der Mei H.C., Norde W. Pluronic-lysozyme conjugates as anti-adhesive and antibacterial bifunctional polymers for surface coating. Biomaterials 2011, 32:6333-6341.
23. Fu J., Ji J., Yuan W., Shen J. Construction of anti-adhesive and antibacterial multilayer films via layer-by-layer assembly of heparin and chitosan. Biomaterials 2005, 26:6684-6692.
24. Tiller J.C., Liao C.J., Lewis K., Klibanov A.M. Designing surfaces that kill bacteria on contact. Proc Natl Acad Sci U S A 2001, 98:5981-5985.
25. Badylak S.F., Coffey A.C., Lantz G.C., Tacker W.A., Geddes L.A. Comparison of the resistance to infection of intestinal submucosa arterial autografts versus polytetrafluoroethylene arterial prostheses in a dog model. JVasc Surg 1994, 19:465-472.
26. Harth K.C., Broome A.M., Jacobs M.R., Blatnik J.A., Zeinali F., Bajaksouzian S., et al. Bacterial clearance of biologic grafts used in hernia repair: an experimental study. Surg Endosc 2011, 25:2224-2229.
27. Milburn M.L., Holton L.H., Chung T.L., Li E.N., Bochicchio G.V., Goldberg N.H., et al. Acellular dermal matrix compared with synthetic implant material for repair of ventral hernia in the setting of peri-operative Staphylococcus aureus implant contamination: a rabbit model. Surg Infec 2008, 9:433-442.
28. Brown P. Abdominal wall reconstruction using biological tissue grafts. AORN J 2009, 90:513-520.
29. Peppas G., Gkegkes I.D., Makris M.C., Falagas M.E. Biological mesh in hernia repair, abdominal wall defects, and reconstruction and treatment of pelvic organ prolapse: a review of the clinical evidence. Am Surg 2010, 76:1290-1299.
30. Franklin M.E., Trevino J.M., Portillo G., Vela I., Glass J.L., Gonzalez J.J. The use of porcine small intestinal submucosa as a prosthetic material for laparoscopic hernia repair in infected and potentially contaminated fields: long-term follow-up. Surg Endosc 2008, 22:1941-1946.
31. Parker D.M., Armstrong P.J., Frizzi J.D., North J.H. Porcine dermal collagen (Permacol) for abdominal wall reconstruction. Curr Surg 2006, 63:255-258.
32. Saettele T.M., Bachman S.L., Costello C.R., Grant S.A., Cleveland D.S., Loy T.S., et al. Use of porcine dermal collagen as a prosthetic mesh in a contaminated field for ventral hernia repair: a case report. Hernia 2007, 11:279-285.
33. Jehle K.S., Rohatgi A. Use of porcine dermal collagen graft and topical negative pressure on infected open abdominal wounds. JWound Care 2007, 16:36-37.
34. Breuing K., Butler C.E., Ferzoco S., Franz M., Hultman C.S., Kilbridge J.F., et al. Incisional ventral hernias: review of the literature and recommendations regarding the grading and technique of repair. Surgery 2010, 148:544-558.
35. Wong L., Dufresne C.R., Richtsmeier J.T., Manson P.N. The effect of rigid fixation on growth of the neurocranium. Plast Reconstr Surg 1991, 88:395-403.
36. Alpert B., Seligson D. Removal of asymptomatic bone plates used for orthognathic surgery and facial fractures. JOral Maxillofac Surg 1996, 54:618-621.
37. Taylor M., Tanner K.E. Fatigue failure of cancellous bone: a possible cause of implant migration and loosening. JBone Jt Surg Br 1997, 79:181-182.
38. Wilson S.K., Costerton J.W. Biofilm and penile prosthesis infections in the era of coated implants: a review. JSex Med 2012, 9:44-53.
39. Badylak S.F., Wu C.C., Bible M., McPherson E. Host protection against deliberate bacterial contamination of an extracellular matrix bioscaffold versus Dacron mesh in a dog model of orthopedic soft tissue repair. JBiomed Mater Res B Appl Biomater 2003, 67:648-654.
40. Menon N.G., Rodriguez E.D., Byrnes C.K., Girotto J.A., Goldberg N.H., Silverman R.P. Revascularization of human acellular dermis in full-thickness abdominal wall reconstruction in the rabbit model. Ann Plast Surg 2003, 50:523-527.
41. Frantz S., Vincent K.A., Feron O., Kelly R.A. Innate immunity and angiogenesis. Circ Res 2005, 96:15-26.
42. Disa J.J., Klein M.H., Goldberg N.H. Advantages of autologous fascia versus synthetic patch abdominal reconstruction in experimental animal defects. Plast Reconstr Surg 1996, 97:801-806.
43. Gretzer C., Gisselfalt K., Liljensten E., Ryden L., Thomsen P. Adhesion, apoptosis and cytokine release of human mononuclear cells cultured on degradable poly(urethane urea), polystyrene and titanium invitro. Biomaterials 2003, 24:2843-2852.
44. Rodriguez A., Meyerson H., Anderson J.M. Quantitative invivo cytokine analysis at synthetic biomaterial implant sites. JBiomed Mater Res A 2009, 89:152-159.
45. Dai J., Rabie A.B. VEGF: an essential mediator of both angiogenesis and endochondral ossification. JDent Res 2007, 86:937-950.
46. Clauss M., Gerlach M., Gerlach H., Brett J., Wang F., Familletti P.C., et al. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. JExp Med 1990, 172:1535-1545.
47. Li B., Jiang B., Dietz M.J., Smith E.S., Clovis N.B., Rao K.M. Evaluation of local MCP-1 and IL-12 nanocoatings for infection prevention in open fractures. JOrthop Res 2010, 28:48-54.
48. Prabhakara R., Harro J.M., Leid J.G., Keegan A.D., Prior M.L., Shirtliff M.E. Suppression of the inflammatory immune response prevents the development of chronic biofilm infection due to methicillin-resistant Staphylococcus aureus. Infect Immun 2011, 79:5010-5018.
49. Asarias J.R., Nguyen P.T., Mings J.R., Gehrich A.P., Pierce L.M. Influence of mesh materials on the expression of mediators involved in wound healing. JInvest Surg 2011, 24:87-98.
50. Di Vita G., Patti R., D'Agostino P., Ferlazzo V., Angileri M., Sieli G., et al. Modifications in the production of cytokines and growth factors in drainage fluids following mesh implantation after incisional hernia repair. Am J Surg 2006, 191:785-790.
51. Zimmerli W., Lew P.D., Waldvogel F.A. Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. JClin Invest 1984, 73:1191-1200.
52. Konstantinovic M.L., Lagae P., Zheng F., Verbeken E.K., De Ridder D., Deprest J.A. Comparison of host response to polypropylene and non-cross-linked porcine small intestine serosal-derived collagen implants in a rat model. Brit J Obstet Gynaecol 2005, 112:1554-1560.
53. Zheng F., Lin Y., Verbeken E., Claerhout F., Fastrez M., De Ridder D., et al. Host response after reconstruction of abdominal wall defects with porcine dermal collagen in a rat model. Am J Obstet Gynecol 2004, 191:1961-1970.
54. Zheng F., Xu L., Verbiest L., Verbeken E., De Ridder D., Deprest J. Cytokine production following experimental implantation of xenogenic dermal collagen and polypropylene grafts in mice. Neurourol Urodyn 2007, 26:280-289.
55. Elieson M., Mixon T., Carpenter J. Coronary stent infections: a case report and literature review. Tex Heart Inst J 2012, 39:884-889.
56. Marculescu C.E., Berbari E.F., Hanssen A.D., Steckelberg J.M., Harmsen S.W., Mandrekar J.N., et al. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 2006, 42:471-478.
57. Donlan R.M. Biofilms: microbial life on surfaces. Emerg Infect Dis 2002, 8:881-890.
58. Kristian S.A., Birkenstock T.A., Sauder U., Mack D., Gotz F., Landmann R. Biofilm formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophil-dependent killing. JInfect Dis 2008, 197:1028-1035.
59. Jensen E.T., Kharazmi A., Garred P., Kronborg G., Fomsgaard A., Mollnes T.E., et al. Complement activation by Pseudomonas aeruginosa biofilms. Microb Pathog 1993, 15:377-388.
60. Trouw L.A., Daha M.R. Role of complement in innate immunity and host defense. Immunol Lett 2011, 138:35-37.
61. Lambris J.D., Ricklin D., Geisbrecht B.V. Complement evasion by human pathogens. Nat Rev Microb 2008, 6:132-142.
62. Hartmann K., Henz B.M., Kruger-Krasagakes S., Kohl J., Burger R., Guhl S., et al. C3a and C5a stimulate chemotaxis of human mast cells. Blood 1997, 89:2863-2870.
63. Dunkelberger J.R., Song W.C. Complement and its role in innate and adaptive immune responses. Cell Res 2010, 20:34-50.
64. Ward P.A., Cochrane C.G., Mueller-Eberhard H.J. The role of serum complement in chemotaxis of leukocytes invitro. JExp Med 1965, 122:327-346.
65. Leid J.G., Willson C.J., Shirtliff M.E., Hassett D.J., Parsek M.R., Jeffers A.K. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. JImmunol 2005, 175:7512-7518.
66. Meluleni G.J., Grout M., Evans D.J., Pier G.B. Mucoid Pseudomonas aeruginosa growing in a biofilm invitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients. JImmunol 1995, 155:2029-2038.
67. Thurlow L.R., Hanke M.L., Fritz T., Angle A., Aldrich A., Williams S.H., et al. Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation invivo. JImmunol 2011, 186:6585-6596.
68. Leid J.G. Bacterial biofilms resist key host defenses. Microbe 2009, 4:66-70.
69. Vuong C., Voyich J.M., Fischer E.R., Braughton K.R., Whitney A.R., DeLeo F.R., et al. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol 2004, 6:269-275.
70. Sarikaya A., Record R., Wu C.C., Tullius B., Badylak S., Ladisch M. Antimicrobial activity associated with extracellular matrices. Tissue Eng 2002, 8:63-71.
71. Brennan E.P., Reing J., Chew D., Myers-Irvin J.M., Young E.J., Badylak S.F. Antibacterial activity within degradation products of biological scaffolds composed of extracellular matrix. Tissue Eng 2006, 12:2949-2955.
72. Holtom P.D., Shinar Z., Benna J., Patzakis M.J. Porcine small intestine submucosa does not show antimicrobial properties. Clin Orthop Relat Res 2004, 18-21.